Details of the Drug Formulaction

General Information of Drug Formulation (ID: F05290)

• Formulation Name: Delavirdine 200 mg tablet
• Company: Kaiser Foundation Hospitals; ViiV Healthcare Company

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Delavirdine	(DM3NF5G)	Human immunodeficiency virus infection	1C62	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Carmellose sodium	(E00625)	Not Available	Disintegrant
Magnesium stearate	(E00208)	11177	lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent